Trial Profile
A trial of bupivacaine controlled release [POSIMIR] versus bupivacaine hydrochloride in patients undergoing laparoscopic cholecystectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 06 Nov 2015 New trial record
- 23 Jun 2015 Results of post hoc analysis from this trial has been published in a DURECT Corporation media release.